Art, Science Offer Freedom But Entail Responsibility

The National Endowment for the Arts, administering a paltry budget of $176 million, has been under congressional attack over the past few years. Various works of art--from Robert Mapplethorpe's homoerotic photographs to Holly Hughes's sexually provocative performance art--have caught our lawmakers' attention. In some cases their interest may well have taken the form of contemplative appreciation; in others, though, the reaction was one of moral outrage. Earlier this year, John Frohnmayer, NEA's

Written byRoald Hoffmann
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The National Endowment for the Arts, administering a paltry budget of $176 million, has been under congressional attack over the past few years. Various works of art--from Robert Mapplethorpe's homoerotic photographs to Holly Hughes's sexually provocative performance art--have caught our lawmakers' attention. In some cases their interest may well have taken the form of contemplative appreciation; in others, though, the reaction was one of moral outrage.

Earlier this year, John Frohnmayer, NEA's head, resigned (or was forced to resign). Two panels of expert reviewers also suspended their activities or resigned from NEA, in protest over the agency's modification of their decisions.

Legislation repeatedly has been introduced by Sen. Jesse Helms (R-N.C.), stipulating that no federal monies be used to subsidize works of art that are "patently offensive" to the public. Helms's riders have come close to being enacted; only a "corn for porn" legislative compromise prevented the last such bill ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies